My Attendance at the 2024 Boston Society Cell and Gene Therapy Conference
My fellow Altascientists and I recently attended the 2024 annual Boston Society Gen
The Next Generation of Non-Rodent Species for Nonclinical Studies
Embracing Change
If you missed our latest webinar in collaboration with Sinclair Bio Resources, The Next Generation Non-Rodent Model for (Bio)Pharmaceuticals Safety Assessment, it’s not too late! The on-demand version is now available.
You’ll learn about the increasing role of miniature swine in drug development and the distinct advantages offered by the Sinclair Nanopig™ model—from availability across all ages to comparable toxicological data with Göttingen™ minipigs and other non-rodent species.
If you have questions about your nonclinical studies, speak with one of our experts.
You may also be interested in:
- Webpage: Miniature Swine in Nonclinical Studies
- Webinar: How to Select the Right Species for Your Toxicology Program
- Scientific Article: A Changing Paradigm for Non-Rodent Species in Nonclinical Studies